Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.

Xu M, Hou R, Sato-Hayashizaki A, Man R, Zhu C, Wakabayashi C, Hirose S, Adachi T, Tsubata T.

J Immunol. 2013 Jun 1;190(11):5436-45. doi: 10.4049/jimmunol.1203576. Epub 2013 Apr 24.

2.

A bacterial artificial chromosome transgene with polymorphic Cd72 inhibits the development of glomerulonephritis and vasculitis in MRL-Faslpr lupus mice.

Oishi H, Tsubaki T, Miyazaki T, Ono M, Nose M, Takahashi S.

J Immunol. 2013 Mar 1;190(5):2129-37. doi: 10.4049/jimmunol.1202196. Epub 2013 Jan 30.

3.

FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.

Yajima K, Nakamura A, Sugahara A, Takai T.

Eur J Immunol. 2003 Apr;33(4):1020-9.

4.
5.

Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR.

J Immunol. 2008 Aug 15;181(4):2513-21.

6.

Genetic dissection of vasculitis in MRL/lpr lupus mice: a novel susceptibility locus involving the CD72c allele.

Qu WM, Miyazaki T, Terada M, Lu LM, Nishihara M, Yamada A, Mori S, Nakamura Y, Ogasawara H, Yazawa C, Nakatsuru S, Nose M.

Eur J Immunol. 2000 Jul;30(7):2027-37.

PMID:
10940892
8.
9.

AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.

White CA, Seth Hawkins J, Pone EJ, Yu ES, Al-Qahtani A, Mai T, Zan H, Casali P.

Autoimmunity. 2011 Dec;44(8):585-98. doi: 10.3109/08916934.2011.577128. Epub 2011 May 18. Erratum in: Autoimmunity. 2011 Dec;44(8):664.

10.

Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.

Santiago-Raber ML, Haraldsson MK, Theofilopoulos AN, Kono DH.

J Immunol. 2007 Jun 15;178(12):8195-202.

11.
12.

Expression and function of Fas on cells damaged by gamma-irradiation in B6 and B6/lpr mice.

Booker JK, Reap EA, Cohen PL.

J Immunol. 1998 Nov 1;161(9):4536-41.

13.

Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.

Ratkay LG, Tait B, Tonzetich J, Waterfield JD.

J Autoimmun. 1994 Oct;7(5):561-73.

PMID:
7530961
14.

Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.

Gu L, Weinreb A, Wang XP, Zack DJ, Qiao JH, Weisbart R, Lusis AJ.

J Immunol. 1998 Dec 15;161(12):6999-7006.

15.

Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.

Choi Y, Ramnath VR, Eaton AS, Chen A, Simon-Stoos KL, Kleiner DE, Erikson J, Puck JM.

Clin Immunol. 1999 Oct;93(1):34-45.

PMID:
10497009
16.

A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice.

Komori H, Furukawa H, Mori S, Ito MR, Terada M, Zhang MC, Ishii N, Sakuma N, Nose M, Ono M.

J Immunol. 2006 Jan 1;176(1):395-400.

17.

Lymphoid cell accumulation in salivary glands of autoimmune MRL mice can be due to impaired apoptosis.

Skarstein K, Nerland AH, Eidsheim M, Mountz JD, Jonsson R.

Scand J Immunol. 1997 Oct;46(4):373-8.

18.

Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice.

Fukuyama H, Adachi M, Suematsu S, Miwa K, Suda T, Yoshida N, Nagata S.

J Immunol. 1998 Apr 15;160(8):3805-11.

19.
20.

Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.

Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.

J Rheumatol. 2010 Jan;37(1):60-70. doi: 10.3899/jrheum.090194. Epub 2009 Dec 1.

PMID:
19955044

Supplemental Content

Support Center